Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1977 2
1978 3
1979 2
1982 1
1983 2
1985 2
1986 2
1987 1
1988 4
1989 3
1990 7
1991 7
1992 10
1993 9
1994 28
1995 16
1996 19
1997 17
1998 19
1999 29
2000 21
2001 22
2002 20
2003 25
2004 37
2005 23
2006 41
2007 39
2008 42
2009 21
2010 28
2011 28
2012 25
2013 24
2014 29
2015 34
2016 40
2017 34
2018 25
2019 26
2020 27
2021 19
2022 27
2023 18
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

802 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer in adolescents and young adults.
Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Johnson RH, et al. Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28. Pediatr Blood Cancer. 2018. PMID: 30156052 Free PMC article. Review.
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for 5.6% of all invasive breast cancer in women. In comparison with older women, AYAs are more likely to have familial c
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for
Breast cancer genes: beyond BRCA1 and BRCA2.
Filippini SE, Vega A. Filippini SE, et al. Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1358-72. doi: 10.2741/4185. Front Biosci (Landmark Ed). 2013. PMID: 23747889 Free article. Review.
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are considered sporadic. ...Due to the development of next generation sequencing technologies, it is envisaged that all familial breast
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are consid
Cancer genetics and breast cancer.
Huber-Keener KJ. Huber-Keener KJ. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:3-11. doi: 10.1016/j.bpobgyn.2022.01.007. Epub 2022 Jan 31. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35272929 Review.
Therefore, it is imperative to identify patients at risk for hereditary breast cancer and to understand the current evidence-based approach to the management of that risk. This chapter focuses on how genes play a role in breast cancer risk, why certain …
Therefore, it is imperative to identify patients at risk for hereditary breast cancer and to understand the current evidence-b …
Molecular Testing in Breast Cancer.
Litton JK, Burstein HJ, Turner NC. Litton JK, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099622 Free article. Review.
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a family history of breast cancer or other tumors, bilateral breast cancers, or early-onset breast cancers warrant …
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a f …
Breast cancer screening in young women.
Desreux JAC. Desreux JAC. Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:208-211. doi: 10.1016/j.ejogrb.2018.05.018. Epub 2018 May 24. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29804884 Review.
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, targeting only some young high-risk women, may be beneficial although no randomized trial has proven an impact on breast cancer mortal
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, targetin
Genetic Epidemiology of Breast Cancer in Latin America.
Zavala VA, Serrano-Gomez SJ, Dutil J, Fejerman L. Zavala VA, et al. Genes (Basel). 2019 Feb 18;10(2):153. doi: 10.3390/genes10020153. Genes (Basel). 2019. PMID: 30781715 Free PMC article. Review.
The last 10 years witnessed an acceleration of our understanding of what genetic factors underpin the risk of breast cancer. Rare high- and moderate-penetrance variants such as those in the BRCA genes account for a small proportion of the familial risk of …
The last 10 years witnessed an acceleration of our understanding of what genetic factors underpin the risk of breast cancer. R …
Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management.
Yoshimura A, Imoto I, Iwata H. Yoshimura A, et al. Int J Mol Sci. 2022 Jul 5;23(13):7481. doi: 10.3390/ijms23137481. Int J Mol Sci. 2022. PMID: 35806485 Free PMC article. Review.
Approximately 5-10% of all breast cancer (BC) cases are caused by germline pathogenic variants (GPVs) in various cancer predisposition genes (CPGs). The most common contributors to hereditary BC are BRCA1 and BRCA2, which are associated with hereditary bre
Approximately 5-10% of all breast cancer (BC) cases are caused by germline pathogenic variants (GPVs) in various cancer
Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V. Mahdavi M, et al. J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14. J Cell Physiol. 2019. PMID: 30552672 Review.
The most important cause of developing hereditary breast cancer is germline mutations occurring in breast cancer (BCs) susceptibility genes, for example, BRCA1, BRCA2, TP53, CHEK2, PTEN, ATM, and PPM1D. ...Germline mutations in BRCA1 and BRCA2 genes ar …
The most important cause of developing hereditary breast cancer is germline mutations occurring in breast cancer
Contrast-enhanced MRI for breast cancer screening.
Mann RM, Kuhl CK, Moy L. Mann RM, et al. J Magn Reson Imaging. 2019 Aug;50(2):377-390. doi: 10.1002/jmri.26654. Epub 2019 Jan 18. J Magn Reson Imaging. 2019. PMID: 30659696 Free PMC article. Review.
Multiple studies in the first decade of the 21(st) century have established contrast-enhanced breast MRI as a screening modality for women with a hereditary or familial increased risk for the development of breast cancer. ...MRI preferentially detects …
Multiple studies in the first decade of the 21(st) century have established contrast-enhanced breast MRI as a screening modality for …
Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.
Toh M, Ngeow J. Toh M, et al. Oncologist. 2021 Sep;26(9):e1526-e1537. doi: 10.1002/onco.13829. Epub 2021 Jun 2. Oncologist. 2021. PMID: 34021944 Free PMC article. Review.
Classically, BRCA1 and BRCA2 germline PVs are associated with significant breast and ovarian cancer risks. Patients with BRCA1 or BRCA2 PVs display worse clinical outcomes but respond better to platinum-based chemotherapies and poly-ADP ribose polymerase inhibitors, …
Classically, BRCA1 and BRCA2 germline PVs are associated with significant breast and ovarian cancer risks. Patients with BRCA1 …
802 results